Ocular Therapeutix, Inc.
OCUL
$7.45
-$0.49-6.17%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 100.25% | 286.45% | 590.16% | 511.05% | 91.40% |
Total Receivables | 24.39% | 29.94% | 10.70% | 25.67% | 22.76% |
Inventory | 31.89% | 6.56% | 15.56% | 13.59% | 16.77% |
Prepaid Expenses | 70.40% | 161.93% | 33.16% | 61.53% | 93.50% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 89.89% | 234.86% | 395.06% | 385.08% | 79.16% |
|
|||||
Total Current Assets | 89.89% | 234.86% | 395.06% | 385.08% | 79.16% |
Net Property, Plant & Equipment | -15.80% | -18.69% | -15.88% | -10.88% | 1.75% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | -8.50% | -8.50% | -8.50% | -8.50% |
Total Assets | 81.68% | 201.98% | 321.92% | 319.18% | 68.84% |
|
|||||
Total Accounts Payable | -4.85% | 0.43% | 3.28% | 18.60% | -14.33% |
Total Accrued Expenses | 22.50% | 5.41% | -5.88% | -27.07% | 18.96% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 21.88% | -8.57% | -56.38% | -15.18% | -0.81% |
Total Finance Division Other Current Liabilities | -49.80% | -40.06% | 277.24% | -43.20% | -55.73% |
Total Other Current Liabilities | -49.80% | -40.06% | 277.24% | -43.20% | -55.73% |
Total Current Liabilities | 18.51% | 3.69% | -7.37% | -18.23% | 11.15% |
|
|||||
Total Current Liabilities | 18.51% | 3.69% | -7.37% | -18.23% | 11.15% |
Long-Term Debt | -8.57% | -8.22% | 25.99% | 21.54% | 38.73% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -22.29% | -22.88% | -20.67% | -21.04% | -20.74% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -38.08% | -25.42% | 38.45% | 28.27% | 123.03% |
Total Liabilities | -11.40% | -10.47% | 16.68% | 10.18% | 41.28% |
|
|||||
Common Stock & APIC | 52.96% | 76.68% | 76.46% | 78.18% | 20.93% |
Retained Earnings | -27.74% | -26.08% | -20.72% | -17.81% | -13.09% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 246.03% | 4,382.63% | 12,135.02% | 4,101.25% | 157.59% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 246.03% | 4,382.63% | 12,135.02% | 4,101.25% | 157.59% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 246.03% | 4,382.63% | 12,135.02% | 4,101.25% | 157.59% |
|